Clinical Trials Directory

Trials / Enrolling By Invitation

Enrolling By InvitationNCT04066608

Prevalence of Advanced Fibrosis in Patients Living With HIV

Cross-sectional Study on the Prevalence of Fatty Liver and Metabolic Risk Factors in an HIV-infected Population

Status
Enrolling By Invitation
Phase
Study type
Observational
Enrollment
300 (estimated)
Sponsor
Johannes Gutenberg University Mainz · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Accepted

Summary

Monocentric, cross-sectional study to define the prevalence of advanced fibrosis in an HIV infected outpatient population. Follow-up over 10 years to assess clinical relevance.

Detailed description

Globally a shift in the spectrum of diseases has occurred. While in earlier year's infectious (communicable) disease were the main contributors to morbidity and mortality, today non-communicable diseases (NCD) exhibit a dramatic increase and have reached epidemic proportions, even in developing countries. Diabetes, cardiovascular disease, and cancer are the most frequent NCDs and the underlying risk factors including Insulin resistance, dyslipidemia and obesity have been increasing over the last decades. The current study explores the prevalence of advanced fibrosis in an HIV-infected outpatient study population.

Conditions

Timeline

Start date
2018-10-01
Primary completion
2028-10-01
Completion
2028-10-01
First posted
2019-08-26
Last updated
2023-12-28

Locations

2 sites across 1 country: Germany

Source: ClinicalTrials.gov record NCT04066608. Inclusion in this directory is not an endorsement.

Prevalence of Advanced Fibrosis in Patients Living With HIV (NCT04066608) · Clinical Trials Directory